Results 221 to 230 of about 220,949 (359)
Commentary on “Maes R. Tuberculosis serology is useful in rural areas: BBRJ 2017;1(2):85-93”
BhaskarC Harinath, Lingaraja Jena
openalex +1 more source
Post-infectious Cytomegalovirus Rhombencephalitis in an Immunocompetent Adult: A Case Report. [PDF]
Ur Rehman M, Saeed H.
europepmc +1 more source
What's New? Adult T‐cell leukemia/lymphoma (ATL) is a rare and aggressive malignancy caused by human T‐cell leukemia virus type 1 (HTLV‐1). The authors comprehensively analyzed the epidemiological and clinical features of ATL over a 30‐year period in French Guiana, a region with high HTLV‐1 endemicity and a multiethnic population.
Jill‐Léa Ramassamy +16 more
wiley +1 more source
Autoimmune thyroid disease in inborn errors of immunity: a retrospective perspective. [PDF]
Bayrak Durmaz MS +4 more
europepmc +1 more source
What's New? Disruption of the gut–liver axis has been suggested to play an important role in liver carcinogenesis. However, limited prospective research has explored associations between potentially harmful gut‐derived bacterial products and liver cancer risk.
Cody Z. Watling +36 more
wiley +1 more source
Central Nervous System Vasculitis Due to Ehrlichia canis in a Dog. [PDF]
Benito MB +2 more
europepmc +1 more source
Doppel as an early‐stage biomarker promoting EMT and dissemination in ovarian cancers
What's New? Existing biomarkers for ovarian cancer (OC) lack the sensitivity and specificity needed to consistently distinguish the malignancy from non‐ovarian influences and other cancers. Here, the authors explored the ability of the prion‐like protein Doppel, normally found in the male testes, to detect OC.
Zulfikar Azam +18 more
wiley +1 more source
Rethinking Coeliac Disease Diagnosis: Reflections on the 2025 ESsCD Guidelines. [PDF]
Tye-Din JA.
europepmc +1 more source

